Jingbo Qie

824 total citations
17 papers, 331 citations indexed

About

Jingbo Qie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jingbo Qie has authored 17 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Jingbo Qie's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (3 papers) and Liver physiology and pathology (2 papers). Jingbo Qie is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (3 papers) and Liver physiology and pathology (2 papers). Jingbo Qie collaborates with scholars based in China, United States and Belgium. Jingbo Qie's co-authors include Fuchu He, Mingwei Liu, Yunzhi Wang, Chen Ding, Quan Zhou, Jun Qin, Wanlin Liu, Lei Song, Ruiyang Li and Yi Wang and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Jingbo Qie

17 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingbo Qie China	11	158	83	82	57	48	17	331
Kehan Ren China	11	239 1.5×	121 1.5×	44 0.5×	37 0.6×	23 0.5×	23	378
Kun Zhu China	11	204 1.3×	43 0.5×	28 0.3×	35 0.6×	72 1.5×	20	337
Se Kyu Oh South Korea	9	202 1.3×	46 0.6×	63 0.8×	66 1.2×	45 0.9×	11	353
Danilo Piobbico Italy	15	261 1.7×	98 1.2×	21 0.3×	62 1.1×	41 0.9×	26	439
Jucimara Colombo Brazil	11	249 1.6×	70 0.8×	169 2.1×	37 0.6×	13 0.3×	21	472
Eva M. Verdugo‐Sivianes Spain	12	258 1.6×	90 1.1×	57 0.7×	47 0.8×	25 0.5×	24	440
Amber N. Habowski United States	7	216 1.4×	126 1.5×	43 0.5×	60 1.1×	48 1.0×	11	366
Anna P. Koh United States	7	118 0.7×	60 0.7×	37 0.5×	32 0.6×	31 0.6×	11	382
Shimin Sun China	10	187 1.2×	30 0.4×	40 0.5×	104 1.8×	22 0.5×	17	376

Countries citing papers authored by Jingbo Qie

Since Specialization

Citations

This map shows the geographic impact of Jingbo Qie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingbo Qie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingbo Qie more than expected).

Fields of papers citing papers by Jingbo Qie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingbo Qie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingbo Qie. The network helps show where Jingbo Qie may publish in the future.

Co-authorship network of co-authors of Jingbo Qie

This figure shows the co-authorship network connecting the top 25 collaborators of Jingbo Qie. A scholar is included among the top collaborators of Jingbo Qie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingbo Qie. Jingbo Qie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Yi, Midie Xu, Xiaoli Zuo, et al.. (2025). The critical role of MLKL in hemorrhagic stroke and the therapeutic potential of its associated protein network. Frontiers in Cell and Developmental Biology. 12. 1509877–1509877. 1 indexed citations

Qie, Jingbo, et al.. (2025). Dysregulated ac4C modification of mRNA in a mouse model of early-stage Alzheimer’s disease. Cell & Bioscience. 15(1). 45–45. 1 indexed citations

Fu, Xiutao, Jingbo Qie, Jia‐Feng Chen, et al.. (2024). Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation. International Journal of Biological Macromolecules. 278(Pt 1). 134120–134120. 11 indexed citations

Chen, Lin, Feifei Luo, Jingbo Qie, et al.. (2024). Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma. Advanced Healthcare Materials. 13(29). e2400925–e2400925. 3 indexed citations

Liu, Yunhe, et al.. (2022). Single-Cell Transcriptomic Analysis Reveals Macrophage–Tumor Crosstalk in Hepatocellular Carcinoma. Frontiers in Immunology. 13. 955390–955390. 23 indexed citations

Wu, Wei, et al.. (2022). Data-Independent Acquisition-Based Mass Spectrometry (DIA-MS) for Quantitative Analysis of Human Intestinal Ischemia/Reperfusion. Applied Biochemistry and Biotechnology. 194(9). 4156–4168. 2 indexed citations

Wang, Yuedi, Bo Wang, Gils Roex, et al.. (2022). Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor. Cancer Immunology Immunotherapy. 71(11). 2801–2814. 12 indexed citations

Qie, Jingbo, et al.. (2021). Integrated MicroRNA Expression Profile Reveals Dysregulated miR‐20a‐5p and miR‐200a‐3p in Liver Fibrosis. BioMed Research International. 2021(1). 9583932–9583932. 17 indexed citations

Shen, Chunmei, et al.. (2021). Comparative Proteomics Demonstrates Altered Metabolism Pathways in Cotrimoxazole- Resistant and Amikacin-Resistant Klebsiella pneumoniae Isolates. Frontiers in Microbiology. 12. 773829–773829. 5 indexed citations

10.

Wang, Sheng, et al.. (2021). SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Frontiers in Oncology. 11. 765484–765484. 10 indexed citations

11.

Qie, Jingbo, et al.. (2021). TNF-α–Induced miR-21-3p Promotes Intestinal Barrier Dysfunction by Inhibiting MTDH Expression. Frontiers in Pharmacology. 12. 722283–722283. 12 indexed citations

12.

Liu, Jiazhe, Hongchang Li, Anwei Mao, et al.. (2020). DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Cell Cycle. 19(24). 3622–3631. 26 indexed citations

13.

Li, Wenhua, Jingbo Qie, Yao Zhang, & Jinjia Chang. (2020). Spatiotemporal Changes in Checkpoint Molecule Expression. Advances in experimental medicine and biology. 1248. 167–200. 3 indexed citations

14.

Yuan, Zhen, et al.. (2020). <p>FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p/FOXA1/AGR2 Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 5231–5240. 19 indexed citations

15.

Fu, Xiutao, et al.. (2020). miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis. Frontiers in Oncology. 10. 107–107. 46 indexed citations

16.

Wang, Yunzhi, Lei Song, Mingwei Liu, et al.. (2018). A proteomics landscape of circadian clock in mouse liver. Nature Communications. 9(1). 1553–1553. 124 indexed citations

17.

Sun, Chang, Zhuojun Zhang, Jingbo Qie, et al.. (2018). Genetic polymorphism ofSLC31A1is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation. Oncotarget. 9(35). 23860–23877. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact